Clinical Trial Update: Combination of Irinotecan, Oxaliplatin and Cetuximab for Locally Advanced or Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of irinotecan, oxaliplatin, and cetuximab in locally advanced or metastatic pancreatic cancer has completed and resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Cetuximab (cetuximab)
• Irinotecan (Irinotecan)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: New Mexico Cancer Research Alliance | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-06-14